Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells

Abstract

Vasculogenic mimicry (VM) is a process by which aggressive tumor cells generate non-endothelial cell-lined channels in malignant tumors including hepatocellular carcinoma (HCC). It has provided new insights into tumor behavior and has surfaced as a potential target for drug therapy. The molecular events underlying the process of VM formation are still poorly understood. In this study, we attempted to elucidate the relationship between Notch4 and VM formation in HCC. An effective siRNA lentiviral vector targeting Notch4 was constructed and transfected into Bel7402, a HCC cell line. VM networks were observed with a microscope in a 3 dimensional cell culture system. Cell migration and invasion were evaluated using wound healing and transwell assays. Matrix metalloproteinases (MMPs) activity was detected by gelatin zymography. Furthermore, the role of Notch4 inhibition in Bel7402 cells in vivo was examined in subcutaneous xenograft tumor model of mice. The results showed that downregulation of Notch4 destroyed VM network formation and inhibited migration and invasion of tumor cells in vitro (P<0.05). In vivo, tumor growth was also inhibited in subcutaneous xenograft model (P<0.05). The potential mechanisms might be related with down-regulation of MT1-MMP, MMP-2, MMP-9 expression and inhibition of the activation of MMP2 and MMP9. These results indicated that Notch4 may play an important role in VM formation and tumor invasion in HCC. Related molecular pathways may be used as novel therapeutic targets for HCC antiangiogenesis therapy.

Keywords

vasculogenic mimicry / hepatocellular carcinoma / invasion / Notch4 / matrix metalloproteinase

References

[1] DomeB, HendrixMJ, PakuS, et al. . Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol, 2007, 170(1): 1-15 PMID: 17200177 PMCID: 1762709

[2] KimSK, LeeJ, SongM, et al. . Combination of three angiogenic growth factors has synergistic effects on sprouting of endothelial cell/mesenchymal stem cell-based spheroids in a 3D matrix. J Biomed Mater Res B Appl Biomater, 2016, 104(8): 1535-1543 PMID: 26268584

[3] JainRK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science, 2005, 307(5706): 58-62 PMID: 15637262

[4] BugyikE, Renyi-VamosF, SzaboV, et al. . Mechanisms of vascularization in murine models of primary and metastatic tumor growth. Chin J Cancer, 2016, 35: 19 PMID: 26873579 PMCID: 4752760

[5] ManiotisAJ, FolbergR, HessA, et al. . Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol, 1999, 155(3): 739-752 PMID: 10487832 PMCID: 1866899

[6] TanLY, MintoffC, JohanMZ, et al. . Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome. Oncotarget, 2016, 7(29): 46492-46508 PMID: 27340778 PMCID: 5216812

[7] RaviM, TentuS, BaskarG, et al. . Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells. BMC Cancer, 2015, 15: 768 PMID: 26499490 PMCID: 4619068

[8] YuL, ZhuB, WuS, et al. . Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma. Diagn Pathol, 2017, 12(1): 23 PMID: 28253891 PMCID: 5335811

[9] AhmadiSA, MoinfarM G, MoghaddamK, et al. . Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. Arch Iran Med, 2010, 13(6): 498-503 PMID: 21039005

[10] YaoN, RenK, WangY, et al. . Paris polyphylla suppresses proliferation and vasculogenic mimicry of human osteosarcoma cells and inhibits tumor growth in vivo. Am J Chin Med, 2017, 45(3): 575-598 PMID: 28385078

[11] SunB, ZhangS, ZhangD, et al. . Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep, 2006, 16(4): 693-698 PMID: 16969481

[12] SunT, ZhaoN, ZhaoXL, et al. . Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology, 2010, 51(2): 545-556 PMID: 19957372

[13] SunD, SunB, LiuT, et al. . Slug promoted vasculogenic mimicry in hepatocellular carcinoma. J Cell Mol Med, 2013, 17(8): 1038-1047 PMID: 23815612 PMCID: 3780534

[14] CaoZ, SunB, ZhaoX, et al. . The expression and functional significance of Runx2 in hepatocellular carcinoma: its role in vasculogenic mimicry and epithelial-mesenchymal transition. Int J Mol Sci, 2017, 18(3): E500 PMID: 28264434

[15] HessAR, MargaryanNV, SeftorEA, et al. . Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors. Dev Dyn, 2007, 236(12): 3283-3296 PMID: 17557303

[16] NietoMA. Epithelial plasticity: a common theme in embryonic and cancer cells. Science, 2013, 342(6159): 1234850 PMID: 24202173

[17] ZhouW, HeQ, ZhangC, et al. . BLOS2 negatively regulates Notch signaling during neural and hematopoietic stem and progenitor cell development. Elife, 2016, 5: e18108 PMID: 27719760 PMCID: 5094856

[18] PurowB. Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol, 2012, 727: 305-319 PMID: 22399357 PMCID: 3361718

[19] HardyKM, KirschmannDA, SeftorEA, et al. . Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res, 2010, 70(24): 10340-10350 PMID: 21159651 PMCID: 3057934

[20] ZhuMS, XuLB, ZengH, et al. . Association of Notch1 with vasculogenic mimicry in human hepatocellular carcinoma cell lines. Int J Clin Exp Pathol, 2014, 7(9): 5782-5791 PMID: 25337219 PMCID: 4203190

[21] JueC, LinC, ZhishengZ, et al. . Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling. Oncotarget, 2017, 8(2): 2501-2513 PMID: 27705934

[22] ChengR, KeK C X, et al. . Expression of NOTCH4 affects vasculogenic mimicry formation in hepatocellular carcimoma. J Clin Hepatol (Chinese), 2015, 31(2): 244-247

[23] LiuW, XuG, MaJ, et al. . Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma. Tohoku J Exp Med, 2011, 224(1): 29-39 PMID: 21512310

[24] StepienM, FedirkoV, Duarte-SallesT, et al. . Prospective association of liver function biomarkers with development of hepatobiliary cancers. Cancer Epidemiol, 2016, 40: 179-187 PMID: 26773278

[25] LiuX, ZhangA, XiangJ, et al. . miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Oncol Rep, 2016, 36(3): 1385-1392 PMID: 27461244

[26] Limaverde-SousaG, SternbergC, FerreiraCG. Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents. Cancer Treat Rev, 2014, 40(4): 548-557 PMID: 24360358

[27] SunH, ZhangD, YaoZ, et al. . Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry. Cancer Biol Ther, 2017, 18(4): 205-213 PMID: 28278077 PMCID: 5450737

[28] UyttendaeleH, HoJ, RossantJ, et al. . Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci USA, 2001, 98(10): 5643-5648 PMID: 11344305 PMCID: 33266

[29] ZhangJF, ChenY, QiuXX, et al. . The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study. Tumour Biol, 2016, 37(3): 3797-3805 PMID: 26472724

[30] GramantieriL, GiovanniniC, LanziA, et al. . Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. Liver Int, 2007, 27(7): 997-1007 PMID: 17696940

[31] FunahashiY, ShawberCJ, SharmaA, et al. . Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Vasc Cell, 2011, 3(1): 2 PMID: 21349159 PMCID: 3039832

[32] MittalB, MishraA, SrivastavaA, et al. . Matrix metalloproteinases in coronary artery disease. Adv Clin Chem, 2014, 64: 1-72 PMID: 24938016

[33] MaradniA, KhoshnevisanA, MousaviSH, et al. . Role of matrix metalloproteinases (MMPs) and MMP inhibitors on intracranial aneurysms: a review article. Med J Islam Repub Iran, 2013, 27(4): 249-254 PMID: 24926188 PMCID: 4011417

[34] Jablonska-TrypucA, MatejczykM, RosochackiS. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem, 2016, 31: 177-183 PMID: 27028474

[35] AlcantaraMB, DassCR. Regulation of MT1-MMP and MMP-2 by the serpin PEDF: a promising new target for metastatic cancer. Cell Physiol Biochem, 2013, 31(4-5): 487-494 PMID: 23548673

[36] LiZ, TakinoT, EndoY, et al. . Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis. Cancer Sci, 2017, 108(3): 347-353 PMID: 27987367 PMCID: 5378257